IL17A and cancer: In addition, the main enrichment pathways of common targets were PI3K-Akt signaling pathway, proteoglycans in cancer, MAPK signaling pathway, IL-17 signaling pathway, TNF signaling pathway, apoptosis, Th17 cell differentiation, and other pathways related to inflammation, cancer, apoptosis, and immunity.